Diagnosis & Disease Information

FDA-approved-stamp_G_931409422

Recent 2023 FDA Approvals

Recent FDA approvals include treatments for chronic migraine, type 1 diabetes, blood cancers, tardive dyskinesia and chorea associated with Huntington disease, vasomotor symptoms of menopause, pain and fever, and Fabry disease.

Next post in Pulmonology Information Center